Cargando…
Asymptomatic carotid stenosis: What we can learn from the next generation of randomized clinical trials
Stroke remains an exceedingly incident and prevalent public health burden across the globe, with an estimated 16 million new strokes per annum and prevalence over 60 million, and extracranial internal carotid artery atherosclerotic disease is an important risk factor for stroke. Randomized trials of...
Autores principales: | Rubin, Mark N, Barrett, Kevin M, Brott, Thomas G, Meschia, James F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157468/ https://www.ncbi.nlm.nih.gov/pubmed/25247072 http://dx.doi.org/10.1177/2048004014529419 |
Ejemplares similares
-
Cortical Thinning in High-Grade Asymptomatic Carotid Stenosis
por: Marshall, Randolph S., et al.
Publicado: (2023) -
Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) study: what have we learned from it?
por: Paraskevas, Kosmas I., et al.
Publicado: (2020) -
Carotid Artery Stenting for Asymptomatic Carotid Stenosis: What We Need to Know for Treatment Decision
por: Baek, Jang-Hyun
Publicado: (2023) -
What we can learn from the next generation of experiments
por: Ross, Graham G
Publicado: (1981) -
Management of asymptomatic carotid stenosis
por: Spence, J. David
Publicado: (2020)